Return to Arthritis & Rheumatism Table of Contents Page
|
Special Articles |
|
|---|---|
|
2707 |
Editorial: Nails in the Coffin: Increasing Evidence for the Role of Rheumatic Disease in the Cardiovascular Mortality of Rheumatoid Arthritis |
|
P. A. Bacon and J. N. Townend |
|
|
2711 |
Editorial: Examining Health Disparities in Systemic Lupus Erythematosus |
|
Michael M. Ward |
|
|
2715 |
Review: Immunoglobulin Variable-Region Gene Usage in Systemic Autoimmune Diseases |
|
Thomas Dorner and Peter E. Lipsky |
|
|
2728 |
Review: Inflammatory Bowel Disease and Spondylarthropathy |
|
Simon Smale, Ravinder S. Natt, Timothy R. Orchard, Anthony S. Russell, and Ingvar Bjarnason |
|
|
Rheumatoid Arthritis |
|
|
2737 |
High Incidence of Cardiovascular Events in a Rheumatoid Arthritis Cohort Not Explained by Traditional Cardiac Risk Factors |
|
Inmaculada del Rincon, Ken Williams, Michael P. Stern, Gregory L. Freeman, and Agustin Escalante |
|
|
2746 |
Long-Term Morbidity, Mortality, and Economics of Rheumatoid Arthritis |
|
John B. Wong, Dena R. Ramey, and Gurkirpal Singh |
|
|
2750 |
Selective Lymphocyte Chemokine Receptor Expression in the Rheumatoid Joint |
|
Jeffrey H. Ruth, James B. Rottman, Kenneth J. Katschke, Jr., Shixin Qin, Lijun Wu, Gregory LaRosa, Paul Ponath, Richard M. Pope, and Alisa E. Koch |
|
|
2761 |
Elevated Levels of Small, Low-Density Lipoprotein With High Affinity for Arterial Matrix Components in Patients With Rheumatoid Arthritis: Possible Contribution of Phospholipase A2 to This Atherogenic Profile |
|
Eva Hurt-Camejo, Silvia Paredes, Lluis Masana, German Camejo, Peter Sartipy, Birgitta Rosengren,Javier Pedreno, Joan Carles Vallve, Pere Benito, and Olov Wiklund |
|
|
Osteoarthritis and Cartilage |
|
|
2768 |
The Osteoprotegerin/Receptor Activator of Nuclear Factor [Kappa]B/Receptor Activator of Nuclear Factor [Kappa]B Ligand System in Cartilage |
|
Hajime Komuro, Tsaiwei Olee, Klaus Khn, Jacqueline Quach, Diana C. Brinson, Alex Shikhman, Jean Valbracht, Lilo Creighton-Achermann, and Martin Lotz |
|
|
2777 |
Anabolic and Catabolic Gene Expression Pattern Analysis in Normal Versus Osteoarthritic Cartilage Using Complementary DNA-Array Technology |
|
Thomas Aigner, Alexander Zien, Angelika Gehrsitz, Pia Margarethe Gebhard, and Louise McKenna |
|
|
2790 |
Activation of the Inducible Nitric Oxide Synthase Pathway Contributes to Inflammation-Induced Osteoporosis by Suppressing Bone Formation and Causing Osteoblast Apoptosis |
|
Kenneth J. Armour, Katharine E. Armour, Robert J. van 't Hof, David M. Reid, Xiao-Qing Wei, Foo Y. Liew, and Stuart H. Ralston |
|
|
Systemic Lupus Erythematosus and Autoimmunity |
|
|
2797 |
Systemic Lupus Erythematosus in Three Ethnic Groups. IX. Differences in Damage Accrual |
|
Graciela S. Alarcon, Gerald McGwin, Jr., Alfred A. Bartolucci, Jeffrey Roseman, Jeffrey Lisse, Barri J. Fessler, Holly M. Bastian, Alan W. Friedman, and John D. Reveille, for the LUMINA Study Group |
|
|
2807 |
Linkage Analysis of Human Systemic Lupus Erythematosus-Related Traits: A Principal Component Approach |
|
Shaoqi Rao, Jane M. Olson, Kathy L. Moser, Courtney Gray-McGuire, Gail R. Bruner, Jennifer Kelly, and John B. Harley |
|
|
2819 |
Association of Tumor Necrosis Factor Receptor Type II Polymorphism 196R With Systemic Lupus Erythematosus in the Japanese: Molecular and Functional Analysis |
|
Chika Morita, Takahiko Horiuchi, Hiroshi Tsukamoto, Nobuaki Hatta, Yuji Kikuchi, Yojiro Arinobu, Takeshi Otsuka, Takuya Sawabe, Shin-ichi Harashima, Kohei Nagasawa, and Yoshiyuki Niho |
|
|
Systemic Sclerosis |
|
|
Improvement in Skin Thickening in Systemic Sclerosis Associated With Improved Survival |
|
|
Virginia D. Steen and Thomas A. Medsger, Jr. |
|
|
2828 |
|
|
Vasculitis |
|
|
2836 |
Response of Wegener's Granulomatosis to Anti-CD20 Chimeric Monoclonal Antibody Therapy |
|
Ulrich Specks, Fernando C. Fervenza, Thomas J. McDonald, and Marie C. E. Hogan |
|
|
2841 |
PTX3 in Small-Vessel Vasculitides: An Independent Indicator of Disease Activity Produced at Sites of Inflammation |
|
Fausto Fazzini, Giuseppe Peri, Andrea Doni, Giacomo Dell'Antonio, Elena Dal Cin, Enrica Bozzolo, Francesca D'Auria, Luisa Praderio, Gianfranco Ciboddo, Maria Grazia Sabbadini, Angelo A. Manfredi, Alberto Mantovani, and Patrizia Rovere Querini |
|
|
2851 |
Antineutrophil Cytoplasmic Antibodies Stabilize Adhesion and Promote Migration of Flowing Neutrophils on Endothelial Cells |
|
David J. Radford, N. Thin Luu, Peter Hewins, Gerard B. Nash, and Caroline O. S. Savage |
|
|
Drug Mechanisms and Treatment |
|
|
2862 |
Demyelination Occurring During Anti-Tumor Necrosis Factor [alpha] Therapy for Inflammatory Arthritides |
|
Niveditha Mohan, Evelyne T. Edwards, Thomas R. Cupps, Patrick J. Oliverio, Glenn Sandberg, Heidi Crayton, John R. Richert, and Jeffrey N. Siegel |
|
|
2870 |
Statins Prevent Endothelial Cell Activation Induced by Antiphospholipid (Anti-[beta]2-Glycoprotein I) Antibodies: Effect on the Proadhesive and Proinflammatory Phenotype |
|
Pier L. Meroni, Elena Raschi, Cinzia Testoni, Angela Tincani, Genesio Balestrieri, Raffaella Molteni, Munther A. Khamashta, Elena Tremoli, and Marina Camera |
|
|
Immune Regulation |
|
|
2879 |
TIA-1 Regulates the Production of Tumor Necrosis Factor [alpha] in Macrophages, but Not in Lymphocytes |
|
Keiko Saito, Samantha Chen, Monica Piecyk, and Paul Anderson |
|
|
Animal Models |
|
|
2888 |
Adenovirus-Based Overexpression of Tissue Inhibitor of Metalloproteinases 1 Reduces Tissue Damage in the Joints of Tumor Necrosis Factor [alpha] Transgenic Mice |
|
Georg Schett, Silvia Hayer, Makiyeh Tohidast-Akrad, Beatrice Jahn Schmid, Susanne Lang, Birgit Trk, Franz Kainberger, Sylva Haralambous, George Kollias, Andrew C. Newby, Qingbo Xu, Gunter Steiner, and Josef Smolen |
|
|
2899 |
Differential Expression Pattern of the Antiapoptotic Proteins, Bcl-2 and FLIP, in Experimental Arthritis |
|
Harris Perlman, Hongtao Liu, Constantinos Georganas, Alisa E. Koch, Eli Shamiyeh, G. Kenneth Haines III, and Richard M. Pope |
|
|
2909 |
Amelioration of Joint Disease in a Rat Model of Collagen-Induced Arthritis by M40403, a Superoxide Dismutase Mimetic |
|
Daniela Salvemini, Emanuela Mazzon, Laura Dugo, Ivana Serraino, Angela De Sarro, Achille P. Caputi, and Salvatore Cuzzocrea |
|
|
2922 |
Increased Resistance to Collagen-Induced Arthritis in CD44-Deficient DBA/1 Mice |
|
Reinout Stoop, Hidehito Kotani, John D. McNeish, Ivan G. Otterness, and Katalin Mikecz |
|
|
Concise Communications |
|
|
2932 |
The Impact of Ultrasonography on Diagnosis and Management of Patients With Musculoskeletal Conditions |
|
Z. Karim, R. J. Wakefield, P. G. Conaghan, C. A. Lawson, E. Goh, M. A. Quinn, P. Astin, P. O'Connor, W. W. Gibbon, and P. Emery |
|
|
2933 |
Treatment of Longstanding Active Giant Cell Arteritis With Infliximab: Report of Four Cases |
|
Fabrizio Cantini, Laura Niccoli, Carlo Salvarani, Angela Padula, and Ignazio Olivieri |
|
|
Letters |
|
|
2936 |
Infliximab Treatment of Severe Ankylosing Spondylitis: One-Year Followup |
|
Jan Brandt, Hildrun Haibel, Joachim Sieper, Jacqueline Reddig, and Jurgen Braun |
|
|
2937 |
Effects of Anti-Tumor Necrosis Factor [alpha] on Synovium in Patients With Spondylarthropathy: Comment on the Article by Baeten et al |
|
Gaye Cunnane |
|
|
2938 |
Reply |
|
Dominique Baeten, Elli Kruithof, Filip Van den Bosch, Herman Mielants, Eric M. Veys, and Filip De Keyser |
|
|
2939 |
Possible Infection With Brucella in Patients With Spondylitis: Comment on the Article by Brandt et al and the Clinical Images by Mercie and Leleu |
|
Yojana Gokhale |
|
|
2940 |
Correlation Among Macrophage Inflammatory Protein 1[alpha] Levels, Matrix Metalloproteinase 8 Levels, and Systemic Inflammation in Rheumatoid Arthritis: Comment on the Articles by Yamanaka et al and Mattey et al |
|
Werner C. Kullich and Gert Klein |
|
|
2941 |
Reduced Bone Mineral Density in Men With Rheumatoid Arthritis: Comment on the Article by Haugeberg et al |
|
Joan M. Nolla and Lourdes Mateo |
|
|
2941 |
Reply |
|
Tore K. Kvien and Glenn Haugeberg |
|
|
2942 |
Are Cases of Rheumatoid Arthritis in Smokers and Lifelong Nonsmokers Representative of Different Rheumatoid Disease Processes? Comment on the Article by Harrison et al |
|
David Hutchinson |
|
|
2943 |
Disease Activity and Survival in Vasculitis: Comment on the Article by Gayraud et al |
|
Eric L. Matteson |
|
|
2943 |
Reply |
|
Martine Gayraud, Loic Guillevin, and Philippe le Toumelin |
|
|
2943 |
Possible Association Between Glucosamine Treatment and Renal Toxicity: Comment on the Letter by Danao-Camara |
|
Marie-Paule Guillaume and Anne Peretz |
|
|
2944 |
Fetal Cell Trafficking and Dermal Fibrosis: Comment on the Article by Christner et al |
|
Bharath Srivatsa and Elizabeth A. Bonney |
|
|
2945 |
Reply |
|
Paul J. Christner and Carol M. Artlett |
|
|
2946 |
Late-Breaking Abstracts and Second-Year Fellow Abstracts, American College of Rheumatology 2001 Annual Scientific Meeting |
|
2953 |
Reviewers |
|
2958 |
Contents, Volume 44, 2001 |
|
2986 |
Indexes |
|
13A |
ACR Announcements |
|
Cover image: The figure on the cover (from Armour et al, page 2794) illustrates immunofluorescence staining of apoptotic osteoblasts in a section of tibia from a mouse treated with talc. In animals, administration of talc causes inflammation-induced osteoporosis, providing a model to investigate the bone loss associated with many forms of arthritis. In the current study, this model was used to determine the role of inducible nitric oxide synthase. |
|




